Sleep‐Deprivation Serum Induces Mitochondrial Stress in BV2 Cells: Responses to P2Y12 ‐Targeted Pharmacological Modulation

Sleep deprivation (SD) disrupts neuroimmune and metabolic homeostasis, but whether circulating factors generated after sleep loss alter microglial responses to purinergic pharmacological modulation remains unclear. P2Y12 is a microglia‐enriched purinergic receptor that regulates process dynamics, calcium signaling, and microglial interactions with neurons and vascular‐glial interfaces. Here, we established an in vitro serum‐transfer model to test whether serum from sleep‐deprived mice alters mitochondrial and Rhod‐2 fluorescence responses to P2Y12‐targeted compounds in BV2 cells. Mice were subjected to forced‐wheel SD consisting of one wheel revolution every 2 s for 4 h per day over 4 consecutive days, and serum was obtained by cardiac blood collection followed by centrifugation. BV2 cells were treated with control or SD serum in the absence or presence of the P2Y12 antagonist MRS2395 or the P2Y12 agonist 2‐MeSADP. Mitochondrial membrane potential was assessed by JC‐1 red/green ratio imaging, mitochondrial network integrity by MitoTracker‐based segmentation and skeletonization, and Rhod‐2 fluorescence responses by single‐cell F / F 0 imaging. SD serum decreased the JC‐1 ratio, increased maximal depolarization, reduced mitochondrial skeleton length and mitochondrial area fraction, and suppressed Rhod‐2 responses. Under control‐serum conditions, MRS2395 markedly enhanced Rhod‐2 responses, whereas the increase in the area under the Rhod‐2 response curve with 2‐MeSADP was not significant after Holm correction. Under SD‐serum conditions, however, neither compound consistently restored the mitochondrial or Rhod‐2 response profile. Together, these findings link SD‐serum exposure to mitochondrial impairment and attenuated Rhod‐2 fluorescence responses in BV2 cells, and suggest that serum context may influence cellular responses to P2Y12‐targeted compounds.

Authors

Institutions

Publication Details

Journal
The FASEB Journal
Published
2026-11-18
DOI
https://doi.org/10.1096/fj.202603419r
Primary Topic
Adenosine and Purinergic Signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sleep‐Deprivation Serum Induces Mitochondrial Stress in BV2 Cells: Responses to P2Y12 ‐Targeted Pharmacological Modulation

Di Yao, Xinghua Liu, Ensheng Yao, Rong Li et al.
The FASEB Journal
Adenosine and Purinergic Signaling
article

Sleep‐Deprivation Serum Induces Mitochondrial Stress in BV2 Cells: Responses to P2Y12 ‐Targeted Pharmacological Modulation

Di Yao, Xinghua Liu, Ensheng Yao, Rong Li, Ya Hao, Lihan Su
article en

Abstract

Sleep deprivation (SD) disrupts neuroimmune and metabolic homeostasis, but whether circulating factors generated after sleep loss alter microglial responses to purinergic pharmacological modulation remains unclear. P2Y12 is a microglia‐enriched purinergic receptor that regulates process dynamics, calcium signaling, and microglial interactions with neurons and vascular‐glial interfaces. Here, we established an in vitro serum‐transfer model to test whether serum from sleep‐deprived mice alters mitochondrial and Rhod‐2 fluorescence responses to P2Y12‐targeted compounds in BV2 cells. Mice were subjected to forced‐wheel SD consisting of one wheel revolution every 2 s for 4 h per day over 4 consecutive days, and serum was obtained by cardiac blood collection followed by centrifugation. BV2 cells were treated with control or SD serum in the absence or presence of the P2Y12 antagonist MRS2395 or the P2Y12 agonist 2‐MeSADP. Mitochondrial membrane potential was assessed by JC‐1 red/green ratio imaging, mitochondrial network integrity by MitoTracker‐based segmentation and skeletonization, and Rhod‐2 fluorescence responses by single‐cell F / F 0 imaging. SD serum decreased the JC‐1 ratio, increased maximal depolarization, reduced mitochondrial skeleton length and mitochondrial area fraction, and suppressed Rhod‐2 responses. Under control‐serum conditions, MRS2395 markedly enhanced Rhod‐2 responses, whereas the increase in the area under the Rhod‐2 response curve with 2‐MeSADP was not significant after Holm correction. Under SD‐serum conditions, however, neither compound consistently restored the mitochondrial or Rhod‐2 response profile. Together, these findings link SD‐serum exposure to mitochondrial impairment and attenuated Rhod‐2 fluorescence responses in BV2 cells, and suggest that serum context may influence cellular responses to P2Y12‐targeted compounds.

The FASEB JournalVol. 40(22)
Shihezi University (CN), First Affiliated Hospital of Shihezi University Medical College (CN), Zaozhuang University (CN), Tongji Hospital (CN), Huazhong University of Science and Technology (CN)
Adenosine and Purinergic Signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon